knowledge -WSS

knowledge

author：hotspot 2025-08-18 14:25:23 Page View：71468

om DiLenge (CQ in grey suit ) Flagship Pioneering Cambridge with US Congressman Raja Krishnamoorthi of Illinois were talking together at the event. Biotech companies demonstrating their medicines and materials at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge. The growing US backlash against the perceived national security threat posed by China's rising biotech industry — Tom DiLenge of Flagship Pioneering (left) with U.S. Congressman Raja Krishnamoorthi of Illinois at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge, Mass. David L Ryan/The Boston Globe

CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of the U.S. economy, such as technology, manufacturing, and clean energy.

Now, some in Congress are raising alarms about China’s threat to another vital industry: biotechnology.

A bipartisan group of lawmakers visited Massachusetts this week to call attention to that threat and call for strengthening U.S. life sciences companies, protecting their technologies, and safeguarding Americans’ genetic data from a Chinese biotech industry with close ties to the authoritarian state.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After decades in use, heart stents finally beat placebo
Next article： DIEP, the 'gold standard' of breast reconstruction, is under threat

focus

First U.S. drug developed to treat liver disease MASH is approved

AdobeTheFoodandDrugAdministrationonThursdayapprovedthefirstmedicinedevelopedspecificallytotreatthese

knowledge

explore

focus

First U.S. drug developed to treat liver disease MASH is approved